Compare Enbridge Inc (ENB) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Mesoblast Limited — how do they compare? Enbridge Inc trades at $51.97 (market cap $112.62B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Enbridge Inc is far larger — about 51× Mesoblast Limited's market cap, and Enbridge Inc pays a 5.34% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| ENB | MESO | |
|---|---|---|
Market Cap | $112.62B | $2.21B |
Sector | Energy | Technology |
52-Week High | $58.04 | $20.96 |
52-Week Low | $45.23 | $12.88 |
Enterprise Value | $196.53B | $2.21B |
Dividend Yield | 5.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
